Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 24, 2024
Product Development

Rare Disease Spotlight: Niemann-Pick pipeline behind two approvals

Therapies aim to enhance lysosomal function to clear cholesterol and glycosphingolipids, mostly via small molecules
BioCentury | Apr 30, 2024
Distillery Therapeutics

SNX8 overexpression for lysosomal storage diseases

BioCentury | Sep 6, 2018
Finance

Evox populates its pipeline

Why exosome therapeutics play Evox is focusing first on rare diseases
BioCentury | Jan 9, 2018
Distillery Therapeutics

Autoimmune disease

BioCentury | Jan 5, 2018
Company News

Mallinckrodt acquiring Sucampo

Items per page:
1 - 10 of 48